Michelle Bourne

5.1k total citations
20 papers, 753 citations indexed

About

Michelle Bourne is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Michelle Bourne has authored 20 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Infectious Diseases. Recurrent topics in Michelle Bourne's work include Asthma and respiratory diseases (16 papers), Antifungal resistance and susceptibility (7 papers) and Respiratory and Cough-Related Research (7 papers). Michelle Bourne is often cited by papers focused on Asthma and respiratory diseases (16 papers), Antifungal resistance and susceptibility (7 papers) and Respiratory and Cough-Related Research (7 papers). Michelle Bourne collaborates with scholars based in United Kingdom, Switzerland and United States. Michelle Bourne's co-authors include Andrew J. Wardlaw, Ian Pavord, Christopher E. Brightling, Catherine H. Pashley, Abbie Fairs, Peter Bradding, Joshua Agbetile, William Monteiro, Dhananjay Desai and Salman Siddiqui and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Science Translational Medicine.

In The Last Decade

Michelle Bourne

18 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Bourne United Kingdom	9	577	443	193	156	116	20	753
Z. Hijazi Kuwait	12	198 0.3×	95 0.2×	37 0.2×	159 1.0×	74 0.6×	18	460
Raj Kumar India	11	228 0.4×	188 0.4×	29 0.2×	141 0.9×	39 0.3×	49	428
Alessia Marseglia Italy	16	546 0.9×	342 0.8×	13 0.1×	348 2.2×	82 0.7×	22	780
Lawrence Shih-Hsin Wu Taiwan	14	151 0.3×	84 0.2×	78 0.4×	36 0.2×	122 1.1×	39	512
Mazen Al‐Alawi Ireland	10	175 0.3×	265 0.6×	61 0.3×	34 0.2×	70 0.6×	14	465
Kristina Warstedt Sweden	6	136 0.2×	60 0.1×	36 0.2×	105 0.7×	70 0.6×	8	448
J Wiśniewski United States	13	317 0.5×	110 0.2×	10 0.1×	244 1.6×	162 1.4×	23	593
Livingstone Chishimba United Kingdom	6	200 0.3×	212 0.5×	180 0.9×	34 0.2×	17 0.1×	8	407
Masayoshi Hosoda Japan	8	141 0.2×	176 0.4×	73 0.4×	17 0.1×	121 1.0×	10	428
Anna Padovani Italy	7	257 0.4×	134 0.3×	31 0.2×	46 0.3×	176 1.5×	13	417

Countries citing papers authored by Michelle Bourne

Since Specialization

Citations

This map shows the geographic impact of Michelle Bourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Bourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Bourne more than expected).

Fields of papers citing papers by Michelle Bourne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Bourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Bourne. The network helps show where Michelle Bourne may publish in the future.

Co-authorship network of co-authors of Michelle Bourne

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Bourne. A scholar is included among the top collaborators of Michelle Bourne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Bourne. Michelle Bourne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McAuley, Hamish, Omer Elneima, Hnin Aung, et al.. (2025). Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization. NEJM Evidence. 4(6). EVIDoa2500012–EVIDoa2500012. 5 indexed citations

Woolnough, Kerry, William Monteiro, Michelle Craner, et al.. (2024). Identification of allergens from Aspergillus fumigatus—Potential association with lung damage in asthma. Allergy. 79(5). 1208–1218. 2 indexed citations

Woolnough, Kerry, Paul J. Seear, Abbie Fairs, et al.. (2020). The airway fungal microbiome in asthma. Clinical & Experimental Allergy. 50(12). 1325–1341. 38 indexed citations

Kaul, Himanshu, Rachid Berair, Sherif Gonem, et al.. (2019). Prostaglandin D2 type 2 receptor antagonism reduces airway smooth muscle mass in asthma: mechanistic insights from in vitro and computational models. The Novartis Repository (Novartis).

Saunders, Ruth, Himanshu Kaul, Rachid Berair, et al.. (2019). DP ₂ antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment. Science Translational Medicine. 11(479). 54 indexed citations

Saunders, Ruth, Himanshu Kaul, Rachid Berair, et al.. (2017). Fevipiprant (qaw039) Reduces Airway Smooth Muscle Mass In Asthma Via Antagonism Of The Prostaglandin D2 Receptor 2 (dp2). 4 indexed citations

Saunders, Ruth, Himanshu Kaul, Rachid Berair, et al.. (2017). Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism. OA283–OA283. 1 indexed citations

Woolnough, Kerry, Matthew Richardson, Chris Newby, et al.. (2016). The relationship between biomarkers of fungal allergy and lung damage in asthma. Clinical & Experimental Allergy. 47(1). 48–56. 55 indexed citations

Gonem, Sherif, Rachid Berair, Amisha Singapuri, et al.. (2016). Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine. 4(9). 699–707. 184 indexed citations

10.

Berair, Rachid, Sherif Gonem, Amisha Singapuri, et al.. (2015). Effect Of Qaw039, An Oral Prostaglandin D2 Receptor (dp2/crth2) Antagonist, Upon Sputum And Bronchial Eosinophilic Inflammation And Clinical Outcomes In Treatment-Resistant Asthma: A Phase 2a Randomized Placebo-Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 191. 6 indexed citations

11.

Berair, Rachid, Sherif Gonem, Amisha Singapuri, et al.. (2015). LATE-BREAKING ABSTRACT: Effect of QAW039, an oral prostaglandin D2 receptor (DP2/CRTh2) antagonist, upon bronchial epithelial integrity in treatment-resistant asthma in a randomized, placebo controlled study. OA290–OA290. 8 indexed citations

12.

Gonem, Sherif, Rachid Berair, Amisha Singapuri, et al.. (2014). Late-breaking abstract: Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTh2) antagonist QAWo39 in eosinophilic asthma. 44. 2908. 6 indexed citations

13.

Agbetile, Joshua, Michelle Bourne, Abbie Fairs, et al.. (2013). Effectiveness of voriconazole in the treatment of Aspergillus fumigatus–associated asthma (EVITA3 study). Journal of Allergy and Clinical Immunology. 134(1). 33–39. 58 indexed citations

14.

Agbetile, Joshua, Michelle Bourne, Abbie Fairs, et al.. (2013). S90 Effectiveness of Voriconazole In the Treatment of Aspergillus fumigatus Associated Asthma. Thorax. 68(Suppl 3). A48.2–A48.

15.

Agbetile, Joshua, Abbie Fairs, Dhananjay Desai, et al.. (2012). Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.. Leicester Research Archive (University of Leicester). 4 indexed citations

16.

Agbetile, Joshua, Abbie Fairs, Dhananjay Desai, et al.. (2012). Isolation of filamentous fungi from sputum in asthma is associated with reduced post‐bronchodilator FEV₁. Clinical & Experimental Allergy. 42(5). 782–791. 71 indexed citations

17.

Fairs, Abbie, Joshua Agbetile, Michelle Bourne, et al.. (2012). Isolation ofAspergillus fumigatusfrom sputum is associated with elevated airborne levels in homes of patients with asthma. Indoor Air. 23(4). 275–284. 24 indexed citations

18.

Fairs, Abbie, Joshua Agbetile, Beverley Hargadon, et al.. (2010). IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma. American Journal of Respiratory and Critical Care Medicine. 182(11). 1362–1368. 196 indexed citations

19.

Agbetile, Joshua, Abbie Fairs, Michelle Bourne, et al.. (2010). S136 Fungal sputum culture in patients with severe asthma is associated with a reduced post bronchodilator FEV1. Thorax. 65(Suppl 4). A61–A62. 1 indexed citations

20.

Bourne, Michelle, et al.. (1979). Asthma due to industrial use of chloramine.. BMJ. 2(6181). 10–12. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact